63
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Hereditary Prostate Cancer

Pages 25-28 | Published online: 09 Jul 2009

REFERENCES

  • Lynch H, Schnelke G, Kimberling W, et al. Hereditary non-polyposis colorectal cancer (Lynch syndromes I and II). Cancer 1985; 56: 939–51.
  • Narod SA, Feunteun J, Lynch HT, et al. Familial breast-ovarian cancer locus on chromosome 17q1-123. Lancet 1990; 338: 82–3.
  • Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 337–47.
  • Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Survey 1982; 1: 47–69.
  • Grönberg H, Damber L, Damber J-E. Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 1996; 77: 138–43.
  • Woolf CM. An investigation of familial aspects of carcinoma of the prostate. Cancer 1960; 13: 739–44.
  • Krain LS. Some epidemiological variables in prostatic carcinoma in California. Prey Med 1974; 3: 154–9.
  • Meilde AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate 1985; 6: 121–8.
  • Fincham SM, Hill GB, Hanson J, Wijayasinghe C. Epidemiology of prostatic cancer: a case-control study. Prostate 1990; 17: 189–206.
  • Ghadirian P. Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 1991; 19: 43–52.
  • Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146: 1305–7.
  • Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, et al. Familiarity of cancer in Utah. Cancer Res 1994; 54: 2378–85.
  • Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600–8.
  • Aprikan AG, Bazinet M, Plante M, Meshref A, Trudel C, Aroson S, et al. Family history and the risk of prostatic carcinoma in a high risk group of urological patients. J Urol 1995; 154: 404–6.
  • Monfoe KR, Yu MC, Kolonel LN, Coetzee GA, Wikens LR, Ross RK, et al. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nature Med 1995; 1: 827–9.
  • Narod SA, Dupontt A, Cusan L, Diamond P, Gomez JL, Suburu R, et al. The impact of family history on early detection of prostate cancer. Nature Med 1995; 1: 99–101.
  • Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995; 141: 732–40.
  • Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, et al. Prostate Cancer Risk in US blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 361–4.
  • Keetch DW, Rice JP, Suarez BK, Catalona WJ. Familial aspects of prostate cancer: a case control study. J Urol 1995; 154: 2100–2.
  • Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996; 144: 1041–7.
  • Ghadirian P, Howe GR, Hislop TG, Maisonneuve P. Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer 1997; 70: 679–81.
  • Bran O, Kristoffersson U, Lundgren R, Olsson H. The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study. Eur J Cancer 1997; 33: 2237–40.
  • Grönberg H, Damber L, Damber J-E. Studies of genetic factors in prostate cancer in a twin population. J Urol 1994; 152: 1484–9.
  • Smith C. Concordance in twins: methods and inter-pretation. Am J Hum Genet 1974; 26: 454.
  • Smith C. Heritability and concordance rates in mono-zygotic twins. Ann Hum Genet (London) 1970; 34: 85.
  • Page WF, Braun MM, Partin AW, Caporaso N, Walsh P. Heredity and prostate cancer: a study of World War II veteran twins. Prostate 1997; 33: 240–5.
  • Neuhausen SL, Skolnick MH, Cannon-Albright L. Familial prostate cancer studies in Utah. Br J Urol 1997; 79 Suppl 1: 15–20.
  • Matikainen MP, Schleutker J, Smith JR, Visakorpi T, Tammela TLJ, Pukkala E, et al. Epidemiology and genetics of familial prostate cancer in Finland. Eur Urol 1998; 33 Suppl 1: 30.
  • Macklin MT. The genetic basis of human mammary cancer. In: Proceedings of Second National Cancer Conference, NY: ACS, 1954: 1074–87.
  • Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, et al. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 1994; 86: 1860–5.
  • Anderson DE, Badzioch MD. Familial breast cancer risks: effects of prostate and other cancers. Cancer 1993; 72: 114–9.
  • Thiessen EU. Concerning a familial association between breast cancer and both prostatic and uterine malignan-cies. Cancer 1974; 34: 1102–7.
  • Andrieu N, Clavel F, Auquier A, et al. Association between breast cancer and family malignancies. Eur J Cancer 1991; 3: 244–8.
  • Lynch HT, Watson P, Lynch if, et al. Hereditary ovarian cancer. Cancer 1992; Suppl 71: 573–81.
  • Isaacs S, Kiemeney L, Baffoe-Bonnie A, et al. Risk of cancer in relatives of prostate cancer probands. INCI 1995; 87: 991–6.
  • Damber L, Grönberg H, Damber J-E. Familial prostate cancer and possible associated malignancies. Nation-wide register cohort study in Sweden. Int J Cancer 1998; 78: 1–5.
  • Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh P. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367–71.
  • Grönberg H, Damber L, Damber J-E, Iselius L. Segregation analysis of prostate cancer in Sweden. Support for a dominant inheritance. Am J Epidemiol 1997; 146: 552–7.
  • Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, et al. A genome wide search reveals a major susceptibility locus for prostate cancer on chromosome 1. Science 1996; 274: 1371–3.
  • Stattin P. Bergh A, Karlberg L, Tavelin B, Damber J-E. Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancer. Eur Urol 1997; 32: 404–9.
  • Grönberg H, Xu J, Smith JR, Carpten JD, Isaacs SD, Freije D, et al. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res 1997; 57: 4707–9.
  • Grönberg H, Isaacs SD, Smith JR, Carpten JD, Bova GS, Freije D, et al. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 1997; 278: 1251–5.
  • Kupelian PA, Kupelian VA, Witte JS, Macklis R, Klein EA. Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. J Clin Oncol 1997; 15: 1478–80.
  • Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskem D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nature Genetics 1998; 20: 175–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.